abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet
RxNorm concept 307650, clinical drug (scd). Prescribable name: abacavir sulfate 300 MG / lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet.
- RxCUI
- 307650
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/307650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
abacavir (as abacavir sulfate) 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet; abacavir 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet; abacavir 300 MG / lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet
Related concepts
- lamivudine 150 MG (SCDC, consists of)
- zidovudine 300 MG (SCDC, consists of)
- abacavir 300 MG (SCDC, consists of)
- Oral Tablet (DF, has dose form)
- abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet [Trizivir] (SBD, has tradename)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 307650 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/307650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 307650. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.